Tandem Diabetes stock is showing great growth -- but miserable profits.
Don't give up on this healthcare stock too soon.
One product in particular could juice the company's fundamentals, a pundit believes.
Stocks are slightly up this morning as market participants reacted to February's US Durable Goods Report.
Tandem Diabetes climbed as investors focused on its strong outlook for the coming year.
Don't be too quick to ignore these stocks.
EQNX::TICKER_START (OTCPK:CNER),(NASDAQ:PODD),(NASDAQ:TNDM),(NYSE:LLY),(NYSE:ABT) EQNX::TICKER_END
The market has punished them, but don't overlook these stocks.
EQNX::TICKER_START (OTCPK:CNER),(NYSE:NVO),(NASDAQ:TNDM),(NASDAQ:DXCM),(NASDAQ:LXRX) EQNX::TICKER_END
/PRNewswire/ -- Glancy Prongay & Murray LLP ("GPM") announces that investors with substantial losses have opportunity to lead the securities fraud class action...